Form 6-K SASOL LTD For: Apr 19

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934

Report on Form 6-K for April, 2018

Commission File Number 1-31615

Sasol Limited
50 Katherine Street
Sandton 2196
South Africa

(Name and address of registrant's principal executive office)

Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form 20-F __X__ Form 40-F _____
Indicate by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(1): ____
Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a
Form 6-K if submitted solely to provide an attached annual report to security
holders.
Indicate by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(7): ____
Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a
Form 6-K if submitted to furnish a report or other document that the
registrant foreign private issuer must furnish and make public under the laws
of the jurisdiction in which the registrant is incorporated, domiciled or
legally organized (the registrant's "home country"), or under the rules of
the home country exchange on which the registrant's securities are traded, as
long as the report or other document is not a press release, is not required
to be and has not been distributed to the registrant's security holders, and,
if discussing a material event, has already been the subject of a Form 6-K
submission or other Commission filing on EDGAR.
Indicate by check mark whether the registrant by furnishing the information
contained in this Form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of
1934.
Yes _____ No __X__
If "Yes" is marked, indicate below the file number assigned to the registrant
in connection with Rule 12g3-2(b):
82-_______________.d

Enclosures: Sasol publishes production and sales metrics for the nine months
ended 31 March 2018





Sasol Limited
(Incorporated in the Republic of South Africa)
Registration number 1979/003231/06
Sasol Ordinary Share codes: 	JSE: SOL 	NYSE: SSL
Sasol Ordinary ISIN codes: 	ZAE000006896 	US8038663006
Sasol BEE Ordinary Share code:	JSE: SOLBE1
Sasol BEE Ordinary ISIN code: 	ZAE000151817
("Sasol" or "the Company")

Sasol publishes production and sales metrics for the nine months ended 31
March 2018

Sasol has published its production and sales performance metrics for the nine
months ended 31 March 2018 incorporating an update on its Lake Charles
Chemicals Project and information on Sasol's hedging programme on the
Company's website at www.sasol.com, under the Investor Centre section or via
this URL: http://www.sasol.com/investor-centre/financial-reporting/business-
performance-metrics

19 April 2018
Johannesburg

Sponsor: Deutsche Securities (SA) Proprietary Limited

Investor Relations:
Moveshen Moodley, Chief Investor Relations Officer
Telephone: +27 (0) 10 344 8052

Disclaimer - Forward-looking statements: Sasol may, in this document, make
certain statements that are not historical facts and relate to analyses and
other information which are based on forecasts of future results and
estimates of amounts not yet determinable. These statements may also relate
to our future prospects, developments and business strategies. Examples of
such forward-looking statements include, but are not limited to, statements
regarding exchange rate fluctuations, volume growth, increases in market
share, total shareholder return, executing our growth projects, (including
LCCP), oil and gas reserves and cost reductions, including in connection with
our BPEP, RP and our business performance outlook. Words such as "believe",
"anticipate", "expect", "intend", "seek", "will", "plan", "could", "may",
"endeavour", "target", "forecast" and "project" and similar expressions are
intended to identify such forward-looking statements, but are not the
exclusive means of identifying such statements. By their very nature,
forward-looking statements involve inherent risks and uncertainties, both
general and specific, and there are risks that the predictions, forecasts,
projections and other forward-looking statements will not be achieved. If one
or more of these risks materialise, or should underlying assumptions prove
incorrect, our actual results may differ materially from those anticipated.
You should understand that a number of important factors could cause actual
results to differ materially from the plans, objectives, expectations,
estimates and intentions expressed in such forward-looking statements. These
factors are discussed more fully in our most recent annual report on Form 20-
F filed on 28 August 2017 and in other filings with the United States
Securities and Exchange Commission. The list of factors discussed therein is
not exhaustive; when relying on forward-looking statements to make investment
decisions, you should carefully consider both these factors and other
uncertainties and events. Forward-looking statements apply only as of the
date on which they are made, and we do not undertake any obligation to update
or revise any of them, whether as a result of new information, future events
or otherwise. Please note: A billion is defined as one thousand million. All
references to years refer to the financial year ended
30 June. Any reference to a calendar year is prefaced by the word "calendar".
Additional information on our business performance is included in the analyst
book available on our website: www.sasol.com


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant, Sasol Limited, has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized.





Date: 19 April 2018					By: 	/s/ V D Kahla
							Name: 	Vuyo Dominic Kahla
							Title: 	Company Secretary

You May Also Be Interested In

• SASOL LIMITED: PRODUCTION AND SALES METRICS FOR THE NINE MONTHS ENDED 31 MARCH 2024
• /C O R R E C T I O N -- Valcare Medical/
• Omdia forecasts strong recovery in large-area display market for 2024, driven by sporting events and innovative production strategies